Real Time Touch

new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)

Real Time Touch

Akebia Therapeutics Inc patents

Recent patent applications related to Akebia Therapeutics Inc. Akebia Therapeutics Inc is listed as an Agent/Assignee. Note: Akebia Therapeutics Inc may have other listings under different names/spellings. We're not affiliated with Akebia Therapeutics Inc, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "A" | Akebia Therapeutics Inc-related inventors

Compositions and methods for treating anemia

Provided herein are specific doses of, and dosing regimens for, using a hif prolyl hydroxylase inhibitor in treating or preventing anemia, such as anemia secondary to or associated with chronic kidney disease, anemia secondary to or associated with non-dialysis dependent chronic kidney disease anemia associated with or resulting from chemotherapy, or anemia associated with aids.. . ... Akebia Therapeutics Inc

Deuterium-enriched hypoxia-inducible factor prolyl hydroxylase enzyme inhibitors

Provided herein are deuterium-enriched compounds of formula (i), formula (ii), formula (iii), formula (iv), formula (v), and formula (vi). Pharmaceutical compositions comprising the isotope-enriched compounds, and methods of using such compounds are also provided.. ... Akebia Therapeutics Inc

Process for preparing [(3-hydroxypyridine-2-carbonyl)amino]alkanoic acids, esters and amides

Disclosed are processes for preparing [(3-hydroxypyridine-2-carbonyl)amino]-alkanoic acids, derivatives, inter alia, 5-aryl substituted and 5-heteroaryl substituted [(3-hydroxypyridine-2-carbonyl]amino}acetic acids. Further disclosed are methods for making prodrugs of [(3-hydroxypyridine-2-carbonyl)-amino]acetic acids, for example, {(3-hydroxypyridine-2-carbonyl]amino}acetic acid esters and {[3-hydroxypyridine-2-carbonyl]amino}acetic acid amides. ... Akebia Therapeutics Inc

Solid forms of acetic acid, compositions, and uses thereof

Provided herein are solid forms comprising {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions comprising the solid forms, methods of making the solid forms and methods of their use for the treatment of various diseases and/or disorders.. . ... Akebia Therapeutics Inc

Prolyl hydroxylase inhibitors and methods of use

The present disclosure relates to hif-1α prolyl hydroxylase inhibitors, compositions which comprise the hif-1α prolyl hydroxylase inhibitors described herein and to methods for controlling, inter alia, peripheral vascular disease (pvd), coronary artery disease (cad), heart failure, ischemia, and anemia.. . ... Akebia Therapeutics Inc

Methods for stabilizing hypoxia inducible factor-2 alpha as a method for treating cancer

Disclosed herein is {[5-(3-fluorophenyl)-3-hydroxypyridine-2-carbonyl]-amino} acetic acid and the ester and amide prodrugs thereof, that can stabilize hypoxia inducible factor-2 alpha (hif-2α) and thereby provide a method for treating cancer. Further disclosed are compositions which comprise {[5-(3-fluorophenyl)-3-hydroxypyridine-2-carbonyl]-amino} acetic acid and/or a prodrug thereof which can be used to treat cancer.. ... Akebia Therapeutics Inc

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009


This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. is not affiliated or associated with Akebia Therapeutics Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Akebia Therapeutics Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by